Eli Lilly’s Mounjaro Secures Spot on China’s State Insurance List for Diabetes Care
The number of people living with diabetes in China is rising fast. On December 7, 2025, authorities announced that Eli Lilly’s Mounjaro, a weekly injectable diabetes drug, will be added to China’s state health insurance starting January 1, 2026. That move could bring Mounjaro into reach for millions of patients with type 2 diabetes. Mounjaro…